168 related articles for article (PubMed ID: 23803115)
1. Tumor necrosis factor-α 238 G/A polymorphism and risk of hepatocellular carcinoma: evidence from a meta-analysis.
Cheng K; Zhao YJ; Liu L; Wan JJ
Asian Pac J Cancer Prev; 2013; 14(5):3275-9. PubMed ID: 23803115
[TBL] [Abstract][Full Text] [Related]
2. Associations between tumor necrosis factor-α polymorphisms and risk of psoriasis: a meta-analysis.
Zhuang L; Ma W; Cai D; Zhong H; Sun Q
PLoS One; 2013; 8(12):e68827. PubMed ID: 24324571
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-α gene polymorphisms and risk of oral cancer: evidence from a meta-analysis.
Chen FC; Zhang F; Zhang ZJ; Meng SY; Wang Y; Xiang XR; Wang C; Tang YY
Asian Pac J Cancer Prev; 2013; 14(12):7243-9. PubMed ID: 24460282
[TBL] [Abstract][Full Text] [Related]
4. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
Li JF; Zheng EQ; Xie M
Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
[TBL] [Abstract][Full Text] [Related]
5. Tumor Necrosis Factor-Alpha Gene Promoter (TNF-α G-308A) Polymorphisms Increase the Risk of Hepatocellular Carcinoma in Asians: A Meta-Analysis.
Verma HK; Merchant N; Bhaskar LVKS
Crit Rev Oncog; 2020; 25(1):11-20. PubMed ID: 32865907
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of tumor necrosis factor-alpha and hepatocellular carcinoma risk: a HuGE systematic review and meta-analysis.
Wei Y; Liu F; Li B; Chen X; Ma Y; Yan L; Wen T; Xu M; Wang W; Yang J
Dig Dis Sci; 2011 Aug; 56(8):2227-36. PubMed ID: 21336601
[TBL] [Abstract][Full Text] [Related]
7. Association between five types of Tumor Necrosis Factor-α gene polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Wungu CDK; Ariyanto FC; Prabowo GI; Soetjipto ; Handajani R
BMC Cancer; 2020 Nov; 20(1):1134. PubMed ID: 33228594
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive assessment of the association between tumor necrosis factor alpha G238A polymorphism and liver cancer risk.
Tian X; Ma P; Sui C; Li Y; Fu L; Jiang T; Wang Y; Jiang Y
Tumour Biol; 2014 Jan; 35(1):103-9. PubMed ID: 23943369
[TBL] [Abstract][Full Text] [Related]
9. The association between cyclooxygenase-2 1195 G/A polymorphism and hepatocellular carcinoma: evidence from a meta-analysis.
Bu X; Zhao C
Tumour Biol; 2013 Jun; 34(3):1479-84. PubMed ID: 23494177
[TBL] [Abstract][Full Text] [Related]
10. A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer.
Zhang HL; Zhang YJ
Tumour Biol; 2013 Jun; 34(3):1659-65. PubMed ID: 23494178
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor alpha rs1800629 polymorphism and risk of cervical lesions: a meta-analysis.
Li M; Han Y; Wu TT; Feng Y; Wang HB
PLoS One; 2013; 8(8):e69201. PubMed ID: 24015171
[TBL] [Abstract][Full Text] [Related]
12. Three polymorphisms of tumor necrosis factor-alpha and hepatitis B virus related hepatocellular carcinoma: A meta-analysis.
Xiao Q; Fu B; Chen P; Liu ZZ; Wang W; Ye Q
Medicine (Baltimore); 2016 Dec; 95(50):e5609. PubMed ID: 27977601
[TBL] [Abstract][Full Text] [Related]
13. The Tumor Necrosis Factor-α-308 and -238 Polymorphisms and Risk of Hepatocellular Carcinoma for Asian Populations: A Meta-Analysis.
Hu Q; Lou GG; Liu YC; Qian L; Lv BD
Curr Ther Res Clin Exp; 2014 Dec; 76():70-5. PubMed ID: 25352937
[TBL] [Abstract][Full Text] [Related]
14. Association between rs1800629 polymorphism in tumor necrosis factor-α gene and dilated cardiomyopathy susceptibility: Evidence from case-control studies.
Zhang Y; Cao Y; Xin L; Gao N; Liu B
Medicine (Baltimore); 2018 Dec; 97(50):e13386. PubMed ID: 30557992
[TBL] [Abstract][Full Text] [Related]
15. Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea.
Shin SP; Kim NK; Kim JH; Lee JH; Kim JO; Cho SH; Park H; Kim MN; Rim KS; Hwang SG
World J Gastroenterol; 2015 Dec; 21(46):13064-72. PubMed ID: 26672513
[TBL] [Abstract][Full Text] [Related]
16. The TNF-α, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis.
Yang Y; Luo C; Feng R; Bi S
J Cancer Res Clin Oncol; 2011 Jun; 137(6):947-52. PubMed ID: 21107607
[TBL] [Abstract][Full Text] [Related]
17. Association between the HSPA1B ±1267A/G polymorphism and cancer risk: a meta-analysis of 14 case-control studies.
Kuang D; Chen W; Song YZ; Yu YY; Zhang DY; Wu L; Tang J
Asian Pac J Cancer Prev; 2014; 15(16):6855-61. PubMed ID: 25169537
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-12B+1188A/C polymorphism contributes to increased hepatocellular carcinoma susceptibility: evidence from a meta-analysis.
Peng Q; Li S; Lao X; Chen Z; Li R; Qin X
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):735-43. PubMed ID: 25445750
[TBL] [Abstract][Full Text] [Related]
19. [Association between miR-146a single nucleotide polymorphism and genetic susceptibility to hepatocellular carcinoma: a meta-analysis].
Zhang LH; Zhang CY; Dai XZ; Zhang J; Zhang F
Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):749-754. PubMed ID: 29108203
[No Abstract] [Full Text] [Related]
20. Tumor necrosis factor-alpha gene -308G > A polymorphism alters the risk of hepatocellular carcinoma in a Han Chinese population.
Feng H; Kuai JH; Zhang MY; Wang GC; Shi YJ; Zhang JY
Diagn Pathol; 2014 Nov; 9():199. PubMed ID: 25420786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
